NERA PUBLICATIONS


RELATED EXPERTS:
Dr. Lawrence Wu Dr. Andrew Carron Lucy P. Allen Dr. William Baker Dr. Elizabeth BeckerDr. Phillip Beutel Dr. Patrick Conroy Dr. David Harrison Jr.Dr. Harlow Higinbotham Greg Houston Adrian Kemp Mike King Dr. Chantale LaCasse Dr. Emmanuel Llinares Dr. Marcia Kramer Mayer James Mellsop Dr. John Montgomery Dr. W. David MontgomeryDr. Chetan SanghviDr. Ramsey Shehadeh Dr. Jon Wainwright Dr. Mark Williams Dr. Paul BernsteinMatthew Evans Sébastien Gonnet Dr. Anne Gron James Heidell Bradley A. Heys Dr. Graeme Hunter Edward Kee Christopher Laursen Nihan Mert-Beydilli Dr. Ron Miller Dr. Elizabeth Newlon Carlos Pabon-Agudelo Dr. Stephanie Plancich Daniel Radov Dr. Bernard Reddy Sandra Ringelstetter Ennis Dr. Agustin Ros Dr. Vladimir Starkov Dr. Scott Thomas Flavia BainbridgeDr. Esther Bruegger Jennifer Cascone Fauver Dr. Ludwig ChincariniDrew Claxton Jennifer Fish Bastian GottschlingDr. Alan Grant Dr. Alex GrecuTimothy McKenna Dr. Jordan Milev Amparo Nieto Dr. Juan Carlos Ortigas Dr. Pedro Posada Yuko Saito Marco SchönbornSumit SharmaSvetlana Starykh Dr. Sugandha D. TuladharRaymund Wong Katie Cartwright Carina Chambarry Dr. Naoya KanekoDr. Noah KaufmanSukaina Klein Annie Lam Dr. William S. TaylorIvelina Velikova

RELATED PRACTICE AREAS:

RELATED PUBLICATIONS:
Snapshot of Recent Trends in Asbestos Litigation: 2010 UpdateSnapshot of Recent Trends in Asbestos Litigation

Snapshot of Recent Trends in Asbestos Litigation: 2011 Update

By Mary Elizabeth C. Stern, Lucy P. Allen, and Adelina Halim

In this third annual review of recent trends in filings and settlements in asbestos litigation, NERA Vice President Mary Elizabeth C. Stern, Senior Vice President Lucy P. Allen, and Senior Analyst Adelina Halim extend their analysis to cover a full decade from 2001 through 2010, using publicly available data to analyze trends in asbestos-related liabilities of more than 150 companies. In the report, the authors find that as the decade drew to a close, aggregate results continued to be generally favorable to asbestos defendants: filings are down; total indemnity payments have stabilized well below the 2004 highs; and pending claims continue to fall. At the same time, dismissal rates have continued to drop and average dollars per resolved claim have increased. While these trends may appear to lead to higher costs, these changes are consistent with the mix of claims shifting toward more malignancies (as non-malignant filings drop).
 
The authors note that the decade had begun with increasing filings, rising total indemnity payments, and mounting pending claims against defendants. However, by mid-decade, all three trends were reversed, with filings, in particular, falling below 2001 levels. With the close of the decade, filings and payments have stabilized for individual defendants below the mid-decade peaks, but the average claim is more expensive to resolve. Going forward, it is yet to be seen whether the pace of the litigation will change as non-malignant claims no longer clog up certain jurisdictions, and what effect, if any, the new asbestos trusts will have on filings and settlements for still-solvent defendants.